The largest database of trusted experimental protocols

On targetplus d 001810 10

Manufactured by Horizon Discovery

ON-TARGETplus D-001810-10 is a small interfering RNA (siRNA) product from Horizon Discovery. It is a pool of four individual siRNA duplexes designed to target a specific gene. The core function of this product is to provide a tool for gene knockdown experiments in cell-based assays.

Automatically generated - may contain errors

3 protocols using on targetplus d 001810 10

1

HeLa Cell Synchronization and siRNA Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were grown in F12:DMEM 50:50 (Hyclone) with 10% FBS, 2mM L-glutamine and antibiotics in 5% CO2 at 37 °C. Cells were synchronized in G1/S by treatment with 2 mM thymidine (Sigma-Aldrich) for 18-hours. The following siRNAs were used for siRNA transfections: ThermoFisher Silencer Select 4390843 (control non-targeting siRNA) and S9187 and S9188 (M1 and M2 siRNAs targeting MYL5); Dharmacon ON-TARGETplus D-001810-10 (control non-targeting siRNA) and J-011739-03 and J-011739-04 (M3 and M4 siRNAs targeting MYL5) were used as described previously (Torres et al. 2010 (link)). See Table S1 for a list of key reagents and resources used in this study and their pertinent information.
+ Open protocol
+ Expand
2

Lentiviral Knockdown of p53 and p21

Check if the same lab product or an alternative is used in the 5 most similar protocols
Lentiviral expression plasmids pLKO.1-sh-Scr, sh5-MDM2, sh1-p53, sh2-p53, sh1-p21 and sh2-p21 were obtained from Open Biosystems and Biomedicum Functional Genomics Unit (Helsinki, Finland). Lentivirus stocks were produced as described [56 (link)]. To establish BC-3 cell lines stably expressing sh-p53, cells were selected with medium containing 3.5 μg/ml puromycin (Sigma) and to establish TREx BCBL1-Rta (here referred as BCBL1RTA) and BC-3 cell lines stably expressing sh-p21, cells were selected with medium containing 2 μg/ml puromycin (Sigma).
The nonspecific siRNAs control (ON-TARGETplus, D-001810-10) and siRNA against p21 (ON-TARGETplus, L-003471-00) were from Dharmacon (SMARTpool siRNA). Cells were reverse-transfected (2000 cells per well) for 48 h in 96-well view plates (Perkinelmer) using RNAiMax (Invitrogen), and reactivated by indicated treatments for 24 h. For more details see supplemental information.
+ Open protocol
+ Expand
3

HeLa Cell Synchronization and siRNA Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa cells were grown in F12:DMEM 50:50 (Hyclone) with 10% FBS, 2mM Lglutamine and antibiotics in 5% CO2 at 37 o C. Cells were synchronized in G1/S by treatment with 2 mM thymidine (Sigma-Aldrich) for 18-hours. The following siRNAs were used for siRNA treatments: ThermoFisher Silencer Select 4390843 (control non-targeting siRNA) and S9187 and S9188 (M1 and M2 siRNAs targeting MYL5); Dharmacon ON-TARGETplus D-001810-10 (control non-targeting siRNA) and J-011739-03 and J-011739-04 (M3 and M4 siRNAs targeting MYL5) were used as described previously. 39 Please see Table S1 for a list of key reagents and resources used in this study and their pertinent information.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!